• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Pierluigi Benedetti Panici, Stefano Basile, +23 authors Costantino Mangioni
  • Medicine
  • Journal of the National Cancer Institute
  • 2008 (First Published: 16 June 2009)
  • BACKGROUND Pelvic lymph nodes are the most common site of extrauterine tumor spread in early-stage endometrial cancer, but the clinical impact of lymphadenectomy has not been addressed in randomizedContinue Reading
  • Pierluigi Benedetti Panici, Angelo Maggioni, +20 authors C Mangioni
  • Medicine
  • Journal of the National Cancer Institute
  • 2005 (First Published: 2 November 2005)
  • BACKGROUND The role of systematic aortic and pelvic lymphadenectomy in patients with optimally debulked advanced ovarian cancer is unclear and has not been addressed by randomized studies. WeContinue Reading
  • Francesco Cognetti, Enzo Maria Ruggeri, +7 authors Francesco M Boccardo
  • Medicine
  • Annals of oncology : official journal of the…
  • 2011 (First Published: 1 March 2012)
  • BACKGROUND The purpose of the study was to evaluate the benefit of adjuvant chemotherapy (AC) versus surgery alone in patients with muscle-invasive bladder cancer (MIBC). PATIENTS AND METHODS OneContinue Reading
  • Pierluigi Benedetti-Panici, Stefano Greggi, +8 authors Fabio Landoni
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2002
  • PURPOSE Neoadjuvant chemotherapy (NACT) and radical surgery (RS) have emerged as a possible alternative to conventional radiation therapy (RT) in locally advanced cervical carcinoma. In 1990, a phaseContinue Reading
  • Pier Francesco Ferrucci, Paolo Antonio Ascierto, +15 authors Chiara Martinoli
  • Medicine
  • Annals of oncology : official journal of the…
  • 2018
  • Baseline neutrophils and derived neutrophilto-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab P. F. Ferrucci1, P. A. Ascierto2, J. Pigozzo3, M. DelContinue Reading